Mark Rupp is an Infectious Disease physician affiliated with Nebraska Medical Center. OpenAlex indexes 311 publications with 20,331 citations (h-index 61); ClinicalTrials.gov lists 4 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Infectious Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
988102 Nebraska Medical Ctr
Omaha, NE 681988102
Telephone
402-559-4015Registry record last updated 23 Jun 2011.
Clinical trials
- Trial Comparing Peripheral I.V. Catheter Complication Rates of Two Different Catheter Dressings
Sponsor: Solventum US LLC
- Clinical Performance of a Chlorhexidine Antimicrobial Dressing
Sponsor: Solventum US LLC
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Teleflex LLCProgram year202410 payments$13,013openpaymentsdata.cms.gov ↗
- KCI USA, Inc.Program year20233 payments$11,000openpaymentsdata.cms.gov ↗
- Teleflex LLCProgram year20239 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Tetracycline-class Drug53.3%Doxycycline Monohydrate100%Part D<11 patientsLipopeptide Antibacterial46.7%Daptomycin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update
Infection Control and Hospital Epidemiology
2022 - Fighting fear in healthcare workers during the COVID-19 pandemic
Infection Control and Hospital Epidemiology
2020 - Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis
Journal of Clinical Investigation
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Andre Kalil, MD
Nebraska Medical Center
Christopher Kratochvil, MD
Nebraska Medical Center
Dwight Jones, MD
Nebraska Medical Center
Fedja Rochling, MD
Nebraska Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”